Cargando…

10,13-Dimethyl-16-oxo-4,5,6,7,8,9,10,11,12,13,14,15,16,17-tetra­deca­hydro-1H-cyclo­penta­[a]phenanthren-17-yl acetate

In the title compound, C(21)H(30)O(3), the five-membered ring adopts an envelope conformation, the cyclo­hexene ring displays a half-chair conformation and the two cyclo­hexane rings have normal chair conformations. In the crystal structure, weak inter­molecular C—H⋯O hydrogen bonding links the mol­...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Rui, Zhang, Chun-Sheng, Huang, Rong, Wei, Kun
Formato: Texto
Lenguaje:English
Publicado: International Union of Crystallography 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3007217/
https://www.ncbi.nlm.nih.gov/pubmed/21588387
http://dx.doi.org/10.1107/S1600536810028412
_version_ 1782194303434489856
author Shi, Rui
Zhang, Chun-Sheng
Huang, Rong
Wei, Kun
author_facet Shi, Rui
Zhang, Chun-Sheng
Huang, Rong
Wei, Kun
author_sort Shi, Rui
collection PubMed
description In the title compound, C(21)H(30)O(3), the five-membered ring adopts an envelope conformation, the cyclo­hexene ring displays a half-chair conformation and the two cyclo­hexane rings have normal chair conformations. In the crystal structure, weak inter­molecular C—H⋯O hydrogen bonding links the mol­ecules into supra­molecular chains running along [100].
format Text
id pubmed-3007217
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher International Union of Crystallography
record_format MEDLINE/PubMed
spelling pubmed-30072172010-12-30 10,13-Dimethyl-16-oxo-4,5,6,7,8,9,10,11,12,13,14,15,16,17-tetra­deca­hydro-1H-cyclo­penta­[a]phenanthren-17-yl acetate Shi, Rui Zhang, Chun-Sheng Huang, Rong Wei, Kun Acta Crystallogr Sect E Struct Rep Online Organic Papers In the title compound, C(21)H(30)O(3), the five-membered ring adopts an envelope conformation, the cyclo­hexene ring displays a half-chair conformation and the two cyclo­hexane rings have normal chair conformations. In the crystal structure, weak inter­molecular C—H⋯O hydrogen bonding links the mol­ecules into supra­molecular chains running along [100]. International Union of Crystallography 2010-07-24 /pmc/articles/PMC3007217/ /pubmed/21588387 http://dx.doi.org/10.1107/S1600536810028412 Text en © Shi et al. 2010 http://creativecommons.org/licenses/by/2.0/uk/ This is an open-access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.
spellingShingle Organic Papers
Shi, Rui
Zhang, Chun-Sheng
Huang, Rong
Wei, Kun
10,13-Dimethyl-16-oxo-4,5,6,7,8,9,10,11,12,13,14,15,16,17-tetra­deca­hydro-1H-cyclo­penta­[a]phenanthren-17-yl acetate
title 10,13-Dimethyl-16-oxo-4,5,6,7,8,9,10,11,12,13,14,15,16,17-tetra­deca­hydro-1H-cyclo­penta­[a]phenanthren-17-yl acetate
title_full 10,13-Dimethyl-16-oxo-4,5,6,7,8,9,10,11,12,13,14,15,16,17-tetra­deca­hydro-1H-cyclo­penta­[a]phenanthren-17-yl acetate
title_fullStr 10,13-Dimethyl-16-oxo-4,5,6,7,8,9,10,11,12,13,14,15,16,17-tetra­deca­hydro-1H-cyclo­penta­[a]phenanthren-17-yl acetate
title_full_unstemmed 10,13-Dimethyl-16-oxo-4,5,6,7,8,9,10,11,12,13,14,15,16,17-tetra­deca­hydro-1H-cyclo­penta­[a]phenanthren-17-yl acetate
title_short 10,13-Dimethyl-16-oxo-4,5,6,7,8,9,10,11,12,13,14,15,16,17-tetra­deca­hydro-1H-cyclo­penta­[a]phenanthren-17-yl acetate
title_sort 10,13-dimethyl-16-oxo-4,5,6,7,8,9,10,11,12,13,14,15,16,17-tetra­deca­hydro-1h-cyclo­penta­[a]phenanthren-17-yl acetate
topic Organic Papers
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3007217/
https://www.ncbi.nlm.nih.gov/pubmed/21588387
http://dx.doi.org/10.1107/S1600536810028412
work_keys_str_mv AT shirui 1013dimethyl16oxo4567891011121314151617tetradecahydro1hcyclopentaaphenanthren17ylacetate
AT zhangchunsheng 1013dimethyl16oxo4567891011121314151617tetradecahydro1hcyclopentaaphenanthren17ylacetate
AT huangrong 1013dimethyl16oxo4567891011121314151617tetradecahydro1hcyclopentaaphenanthren17ylacetate
AT weikun 1013dimethyl16oxo4567891011121314151617tetradecahydro1hcyclopentaaphenanthren17ylacetate